3rd Due Diligence Summit for Life Sciences - Wyndham Boston Beacon Hill

3rd Due Diligence Summit for Life Sciences
May 18 - 19, 2016
Wyndham Boston Beacon Hill
Boston, MA

Best practices for conducting an efficient and effective due diligence for acquiring or licensing a new product, portfolio, company, and/or entering a strategic alliance

3rd Due Diligence Summit for Life Sciences – 3rd Due Diligence Summit for Life Sciences

Recent years have shown a rise in development across the generic and biosimilar industries, as many blockbuster products near the end of their patents. The need to expand the reach of R&D programs has driven major new investments in co-development, strategic alliances, licensing and acquisitions, with big pharmaceutical companies scrambling to maintain their strongholds on specific therapeutic areas. This has increased the need for a robust due diligence process across all functions, as companies look to external targets as a means of supplementing pipelines and bolstering their product portfolios.

The 3rd Due Diligence Summit for Life Sciences will provide an overview of the proven strategies and insights of due diligence leaders from medical device, biotechnology and pharmaceutical companies and discuss how best to maneuver the rapidly changing landscape of the industry.

Featured Speakers

Top Reasons to Attend

  • EXPLORE BEST PRACTICES for companies of all sizes looking to acquire or in-license a product
  • GAIN valuable insight from cross-functional due diligence team members, as well as leaders in the medical device and biotech industries
  • UNDERSTAND how to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal
  • LEARN how to evaluate and effectively manage strategic alliances through case studies from industry leaders
  • ASSESS the regulatory and compliance standards of a target and how gaps can lead to unforeseen financial burdens
  • HEAR FROM ADDITIONAL FEATURED SPEAKERS representing Zimmer Biomet, Insightra Medical, Analogic Corporation, Boehringer Ingelheim, Bayer, G&W Laboratories, Elanco and other organizations!

Who Should Attend

This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas:

  • Due Diligence
  • Business Development
  • Strategic Alliance/Alliance Management
  • Mergers and Acquisitions
  • Licensing
  • Intellectual Property and Patent Counsel
  • Search and Evaluation
  • Portfolio Management
  • Scientific Assessment
  • General Counsel/Corporate Counsel
  • Legal and Regulatory Compliance
  • Regulatory Affairs
  • Research and Development
  • Clinical Medicine
  • Clinical Operations
  • Life Cycle Management

This event is also of interest to:

  • Investment Banks
  • Private Equity Firms
  • Venture Capitalists
  • Data Room Providers
  • Due Diligence Consultants
  • Law Firms
  • Clinical Affairs and CRO Partners
  • Regulatory Affairs and Compliance Partners

live chat software